Rituximab in refractory myasthenia gravis:: A follow-up study of patients with antil-MuSK or anti-MuSK antibodies

被引:0
|
作者
Illa, Isabel
Diaz-Manera, Jordi
Rojas-Garcia, Ricard
Pradas, Jesus
Rey, Antoni
Blesa, Rafael
Juarez, Candido
Gallardo, Eduard
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A301 / A301
页数:1
相关论文
共 50 条
  • [41] Anti-MuSK Antibody-positive Ocular Myasthenia Gravis
    Yu, J.
    Hwang, J.
    ANNALS OF NEUROLOGY, 2019, 86 : S124 - S124
  • [42] Anti-MuSK myasthenia gravis presenting with purely ocular findings
    Caress, JB
    Hunt, CH
    Batish, SD
    ARCHIVES OF NEUROLOGY, 2005, 62 (06) : 1002 - 1003
  • [43] Passive immunization of mice with anti-MuSK(+) myasthenia gravis serum
    Molenaar, PC
    Plomp, JJ
    Wintzen, AR
    Verschuuren, JJGM
    van Duinen, SG
    Vincent, A
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 754 - 754
  • [44] Prognostic Value of Clinical Response to Acetylcholinesterase Inhibitors in Myasthenia Gravis with Anti-MuSK Antibodies
    Evoli, Amelia
    Guptill, Jeffrey T.
    Batocchi, Anna
    Padua, Luca
    Massey, Janice M.
    Juel, Vern C.
    Bartoccioni, Emanuela
    Hobson-Webb, Lisa
    Sanders, Donald B.
    NEUROLOGY, 2011, 76 (09) : A286 - A287
  • [45] Erratum to: Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies
    Giovanna Cenacchi
    Valentina Papa
    Marina Fanin
    Elena Pegoraro
    Corrado Angelini
    Journal of Neurology, 2011, 258 : 953 - 953
  • [46] The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis
    Cortes-Vicente, Elena
    Rojas-Garcia, Ricard
    Diaz-Manera, Jordi
    Querol, Luis
    Casasnovas, Carlos
    Guerrero-Sola, Antonio
    Luis Munoz-Blanco, Jose
    Eulalio Barcena-Llona, Jose
    Marquez-Infante, Celedonio
    Pardo, Julio
    Maria Martinez-Fernandez, Eva
    Uson, Mercedes
    Oliva-Nacarino, Pedro
    Sevilla, Teresa
    Illa, Isabel
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (06): : 710 - 716
  • [47] Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
    Chayanopparat, Siripong
    Banyatcharoen, Perasin
    Jitprapaikulsan, Jiraporn
    Uawithya, Ekdanai
    Apiraksattayakul, Natnasak
    Viarasilpa, Vasinee
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [48] MUSK INDUCED EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IS ANTI-MUSK IGG1 INDEPENDENT
    Kucukerden, M.
    Huda, R.
    Tuzun, E.
    Strait, R. T.
    Finkelman, F. D.
    Trakas, N.
    Tzartos, S.
    Christadoss, P.
    MUSCLE & NERVE, 2015, 52 : S143 - S143
  • [49] Comparison of thymus pathology of anti-MuSK positive with -MuSK negative and -AChR positive myasthenia gravis
    Bayindir, Cicek
    Gungor-Tuncer, Ozlem
    Parman, Yesim
    Serdaroglu, Piraye
    Saruhan-Direskeneli, Gueher
    Toker, Alper
    Deymeer, Feza
    Bilgic, Bilge
    NEUROMUSCULAR DISORDERS, 2006, 16 : S128 - S128
  • [50] Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies
    Yamashita, Rika
    Shimizu, Mikito
    Baba, Kousuke
    Beck, Goichi
    Kinoshita, Makoto
    Okuno, Tatsusada
    Higuchi, Osamu
    Mochizuki, Hideki
    INTERNAL MEDICINE, 2021, 60 (01) : 137 - 140